- Net loss expanded to approximately $33 million or $0.45 per share in Q3 compared to the prior-year period.
- Cash, equivalents, and investments totaled $216.0M as of Sept 30, 2026, projected to fund operations into 2029.
- Upcoming presentation of initial clinical data for NKX019 at ACR Convergence 2026.
Signal #150916 · SEC 8-K
$NKTX SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $NKTX filing catalyst
Why did $NKTX trigger an AI stock catalyst alert?
$NKTX triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: -0.5/10). Headline: Nkarta Reports Q3 Net Loss of $0.45 per Share, Cash Runway Extended into 2029. Key points: - Net loss expanded to approximately $33 million or $0.45 per share in Q3 compared to the prior-year period. - Cash, equivalents, and investments totaled $216.0M as of Sept 30, 2026, projected to fund operations into 2029. - Upcoming presentation of initial clinical data for NKX019 at ACR Convergence 2026.
How did $NKTX stock react after the SEC filing?
After the SEC 8-K for $NKTX, observed market reaction: T0 price $1.57. Past moves do not guarantee future results.
Where can I get real-time $NKTX SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $NKTX via Telegram and the VIP Web Terminal from €10/month.